Vascular endothelial growth factor and its main receptor vascular endothelial growth factor receptor 2 (VEGFR-2), are overexpressed on tumor vascular endothelial cells and have been identified as targets for antiangiogenic drugs [3-10]. This evidence concerns the gene KDR and neoplasm.